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HIGHLY SELECTIVE MMP-13 INHIBITOR PREVENTS
COLLAGEN DEGRADATION IN HUMAN OA CARTILAGE
D. Piecha1, G. Becher1, J. Boer1, H. Kheil1, T. Powers2,
A. Taveras2, A. Timmermann1, J. VanVeldhuizen2, J. Weik1,
M. Hofmann1
1Alantos Pharmaceuticals, Heidelberg, Germany, 2Alantos
Pharmaceuticals, Cambridge, MA
Purpose: Matrix metalloproteinases (MMPs) have long been
considered as excellent targets for the treatment of osteoarthritis
(OA). However, realization of this concept has been hampered
by dose-limiting musculoskeletal side effects observed in hu-
mans with broad spectrum inhibitors. MMP-13, the major type
II collagenase, is highly up-regulated in OA/RA and therefore
strongly implicated in the pathogenesis of OA. Selective inhibi-
tion of MMP-13 may provide the desired cartilage degradation
protection while overcoming the musculoskeletal toxicity seen by
non-selective inhibition of MMPs.
Methods: Selectivity determination. Kinetic studies. Culture of
bovine and human cartilage explants.
Results: We have identified a new class of very potent and
highly selective MMP-13 inhibitors which showed no activity
against other MMPs, TACE or members of the ADAMTS fam-
ily at concentrations up to 20μM. Kinetic studies specified this
class of compounds as mixed-type, non-zinc binding inhibitors.
Excessive cleavage of type II collagen is a fundamental patho-
logical feature of OA. In cultured explants from OA patients,
collagen degradation was significantly reduced by the selective
MMP-13 inhibitor. Inhibition of collagen degradation was studied
in bovine and human articular cartilage systems, where the carti-
lage degradation was induced by the addition of pro-inflammatory
cytokines IL-1a and oncostatin M. Our highly selective MMP-13
inhibitors completely blocked type II collagen degradation in
bovine explants and showed up to 80% inhibition in human OA
cartilage, while proteoglycan degradation remained unchanged.
These results were confirmed with different biomarkers (C1,2C,
C2C, CTX-II) and hydroxyproline determination which validates
MMP-13 as the primary collagenase in the IL-1/OSM-induced
cartilage degradation process.
Conclusions: Our results emphasize the role of MMP-13 in
pathologic cartilage degradation and verify the value of selective
MMP-13 inhibitors for potential treatment of OA and RA.
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HOW DOES VITAMIN D AFFECT BONE AND CARTILAGE
IN A GUINEA PIG MODEL OF OSTEOARTHRITIS?
T. Hunt1, R. Kandel2, R. Renlund2, R. Vieth2, M. Grynpas1
1Samuel Lunenfeld Research Institute, Mount Sinai Hospital,
Toronto, ON, Canada, 2Department of Laboratory Medicine and
Pathobiology, University of Toronto, Toronto, ON, Canada
Purpose: Clinical studies have shown that changes in bone are
important determinants for the progression of OA and vitamin D
is known to promote bone health. We wish to determine whether
vitamin D supplementation produces any beneficial or detrimen-
tal effects in cartilage and in subchondral bone in Guinea Pig
model of OA.
Methods: Male Dunkin-Hartley guinea pigs spontaneously ac-
quire OA because of a rapid weight increase and by performing
a full lateral menisectomy (MNX) the OA becomes accelerated
and predictable. The MNX was performed on the left leg, right
leg acting as an internal control. Groups of 8 male MNX guinea
pigs will be followed for 1, 3 and 6 months to evaluate the effect
of vitamin D on bone and cartilage. In each time point there are 3
groups; no vitamin D (NVD), control (NT) and high dose vitamin
D (HVD). The NVD group was fed a diet consisting of no vita-
min D, the NT group was fed a normal diet with 153IU/day and
the HVD group was fed an extra 380IU/day. Guinea pigs were
received at 2 months of age; vitamin D treatment was started
upon arrival. After 1 month of acclimatization the MNX was per-
formed and the animals were sacrificed 1, 3 and 6 months after
MNX. To define the response of cartilage to vitamin D sections
of the tibia were stained using Safranin-O and a fast green
counter stain to be evaluated using a modified Mankin grad-
ing. Bone mineral density (BMD) was evaluated using DEXA,
and bone histomorphometric parameters were evaluated using
Bioquant software. Vitamin D serum levels and tissue calcium
accumulation were also investigated. Subchondral bone quality
will be determined including image analysis to determine bone
connectivity, backscattered electron imaging to determine bone
mineralization and micro-hardness to determine stiffness.
Results: Preliminary results for 1 and 3 month time points show
that 1 month after surgery a significant (p<0.05) increase was
seen between treatment groups for blood serum vitamin D levels.
The 1 month BMD showed a significant decrease in the MNX
leg compared to the control in each group (NVD-6.5%; NT-9.4%;
HVD-7.5%), but no differences were seen between the treatment
groups. The 3 month BMD still showed no significant changes
between the treatment groups. 1 month bone histomorphometric
parameters showed an increase for bone volume, osteoid volume
and trabecular number for the proximal tibia and distal femur with
increasing vitamin D treatment. The Mankin score showed a
significant increase in cartilage degeneration in the HVD MNX
leg compared to all other groups. All treatment groups showed
a significantly increased score on the MNX leg compared to
control. Histological results from Von-Kossa staining of the 1
month kidneys showed no significant differences between the
groups.
Conclusions: This study demonstrates that vitamin D intake has
an effect on cartilage and bone in OA. The effect of vitamin D
treatment may not be apparent on BMD 1 month after MNX, but
can be seen in bone histomorphometric properties with increas-
ing bone and osteoid. The increase in bone histomorphometric
properties may point to an increase in bone formation, but further
investigation of bone mineralization and microhardness must be
done to fully understand the effects of vitamin D on subchondral
bone. We also showed that the MNX guinea pig model is a
reliable model of OA, with decreases in BMD in the MNX leg and
increases in Mankin score. The high Mankin score in the HVD
group may mean that the dose given to the guinea pigs is too
high and a dose-response study should be investigated. Further
time points must still be looked at to fully understand the effect
of vitamin D on the bone and cartilage during the progression of
OA.
P136
IL-1 STIMULATES TWO SETS OF CHEMOKINES IN
NORMAL AND ADULT ADULT ARTICULAR
CHONDROCYTES
L.J. Sandell, X. Xing, C. Franz, D. Patra
Washington University, St. Louis, MO
Purpose: IL-1 is a proinflammatory cytokine present during
inflammatory reactions. In OA, IL-1 is present in the synovial
fluid and synthesized by synovial cells and chondrocytes. IL-
1 is known to increase catabolic activity of chondrocytes and
inhibit matrix gene expression. Recently, we have found that IL-1
stimulates the growth and differentiation factor BMP-2 in adult
articular chondrocytes, indicating that IL-1 also may activate a
repair process. These results lead us to hypothesize that IL-1
has many different effects on chondrocytes that may be depend
on time of exposure, concentration of cytokine and location in
S84 Poster Presentations
the cartilage. The purpose of the current study was to determine
the effect of IL-1 on global gene expression in chondrocytes from
individuals with no history of OA and chondrocytes from cartilage
with patients with OA.
Methods: Chondrocytes were isolated from cartilage of a donor
greater than 60 years without history of OA, intact cartilage from
total joint arthroplasty (OA) and a young adult without OA, and
cultured at 106 cells/cm2. IL-1 was added at concentrations of
2 ng/ml for some experiments and 0.1, 1 and 10 ng/ml for other
experiments. In some cultures IL-1 was removed at 24 hrs and
the anabolic factors BMP-2 and TGF-beta1 were added and
cultured for an additional 24 hrs. RNA was isolated by the Trizol
method and cDNA was prepared for microarray analysis using
cDNA arrays of 20,000 human gene transcripts. Microarray data
was verified using semi-quantitative RT-PCR.
Results: Microarray analysis suggested that a large set of
chemokine genes were the most highly responsive to IL-1 stim-
ulating begin increased 25-75 fold by 2 ng/ml (see Table 1). A
second set of chemokines was increased 3-11 fold. The increase
was observed down to a level of 100 pg/ml IL-1. As expected
type II collagen gene expression decreased by 50% and MMP-
13 expression increased 6 fold. Surprisingly, expression of the
aggrecanase, ADAMS-TS5, was present in all cartilages exam-
ined and down-regulated in normal cartilage by 7 fold and in
OA cartilage approximately 5 fold. All results were confirmed by
RT-PCR. BMP-2 was increased by 4 fold. IL-1 autoregulated its
own gene by 20 fold.
Table 1. Gene Expression (fold increase or decrease)
Gene Fold Increase or Decrease
Group 1:
CXCL2 (Gro-b)
CXCL8 (IL-8)
CXCL1 (Gro-1)
CCL4 (MIP-b)
CCL20 (MIP-3a) 25-75
CCL3L1 (LD78b)
CSCL6 (GCP-2)
IL-6CCL3 (MIP-1a)
CCL5 (RANTES)
CSCL5 (ENA-78)
CS3CL5 (Fractalkine) 3-11
CCL2 (MCP-1)
CCL8 (MCP-2)
MMP13 6
BMP-2 4
COL2A1 0.4
ADAMS-TS5 0.13
When the concentration of IL-1 was reduced to 100 pg/ml, the
chemokines were increased while the other effects of IL-1 were
reduced. The same result was observed in all ages of normal
cartilage. For the OA cartilage, gene expression was similar as
the low concentrations of IL-1, however, with addition of IL-1, the
effects were more dramatic. Interestingly, only TGF-BETA could
reverse some, but not all effects.
Conclusions: Two distinct sets of chemokines were the most
highly responsive of all cartilage genes to culture with IL-1. The
effects of IL-1 on other genes vary with the concentration of
the cytokine, but the chemokines are the most responsive. This
indicates that at these genes are differentially regulated. Sur-
prisingly, the aggrecanase gene ADAMS-TS5 was present in all
chondrocytes and down-regulated by IL-1. While the expected
effects of IL-1 were observed, other previously unknown effects
were observed. In addition, these experiments clearly demon-
strate that reactions vary by concentration. Thus even more
complex effects of inflammation on cartilage are revealed.
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INDUCTION OF INCREASED CAMP LEVELS IN
ARTICULAR CHONDROCYTES BLOCKS MATRIX
METALLOPROTEINASE AND AGGRECANASE MEDIATED
CARTILAGE DEGRADATION
M.A. Karsdal1, E. Sumer1, S.H. Madsen1, C. Christiansen2,
P. Qvist1, B.-C. Sondergaard1
1Nordic Bioscience, Herlev, Denmark, 2CCBR, Ballerup,
Denmark
Purpose: Calcitonin has been suggested to have chondropro-
tective effects in joint degenerative diseases. In vitro studies have
demonstrated that one signalling pathway of calcitonin is via the
second messenger cAMP. We investigated whether increased
cAMP levels in chondrocytes would be chondroprotective in a
model of cartilage degradation.
Methods: Cartilage degradation was induced in bovine articular
cartilage explants cultures by stimulation with 10 ng/mL onco-
statin M (OSM) and 20 ng/mL TNF. cAMP levels was stimulated
by treatment with either forskolin (cAMP activator, 1-64 μM) or
IBMX (phosphodiesterase inhibitor, 1-64 μM), and the intracellu-
lar cAMP levels were evaluated by ELISA. Cartilage degradation
was evaluated in the conditioned medium by quantification of
crosslinked C-telopeptide fragments of type II collagen (CTX-II),
matrix metalloproteinase (MMP) mediated aggrecan turnover by
a novel ELISA detecting the 342FFGVG-G2 cleavage site, ag-
grecanase mediated aggrecan turnover by a novel ARGS-G2
ELISA. Biochemical findings were validated by immunohisto-
chemistry of CTX-II fragments and toluidine blue stainings of
proteoglycans. Changes in MMP expression and activity in the
conditioned medium were assessed by gelatine zymography.
Alamarblue was used to evaluate cyto-toxicity after stimulation
with the various compounds and cytokines.
Results: OSM and TNF treatment induced a 500-fold increase
in CTX-II release to the supernatant (P<0.001) compared to
vehicle control. Both forskolin and IBMX dose-dependently in-
hibited CTX-II release (P<0.001), which at the highest concen-
tration was completely abrogated. OSM and TNF induced 8
fold increase in MMP mediated aggrecan degradation (FFGV-
G2), which was dose-dependently inhibited by both forskolin
and IBMX to 75%, (P<0.001). OSM and TNF evoked marked
increases in MMP expression, which was dose-dependently in-
hibited by both forskolin and IBMX. With regards to aggrecanase
activity, OSM and TNF induced a 4 fold increase in ARGS-
G2 degradation products of aggrecan. Forskolin significantly in-
hibited aggrecanase mediated aggrecan degradation by 60%
(P<0.01), whereas IBMX inhibited aggrecanase activity by 40%
albeit non-significant. None of the compounds affected cell num-
ber or viability.
Conclusions: cAMP levels in chondrocytes play a key role in
controlling the catabolic activity. Increased cAMP levels in chon-
drocytes results in inhibition of aggrecanase as well as MMP
expression and activity, and consequently a strong inhibition
of cartilage degradation. Specific cAMP modulators in chon-
drocytes, such as calcitonin, may be potential treatments for
cartilage degenerative diseases.
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ESTROGEN STRONGLY ATTENUATES COLLAGEN-
INDUCED ARTHRITIS IN RATS
R.H. Nielsen1, K.E. Rasmussen1, E.U. Sumer1, A.K. Olsen1,
P. Qvist1, C. Christiansen2, M.A. Karsdal1
1Nordic Bioscience A/S, Herlev, Denmark, 2CCBR, Ballerup,
Denmark
Purpose: To investigate the effects of estrogen compared to
